Related Experiment Video
Updated: May 4, 2026

Concanavalin A-Based Sedimentation Assay to Measure Substrate Binding of Glucan Phosphatases
Published on: December 23, 2022
Kinetic properties of carbohydrate-lectin interactions: FimH antagonists
Meike Scharenberg1, Xiaohua Jiang, Lijuan Pang
1Institute of Molecular Pharmacy, Pharmacenter, University of Basel, Klingelbergstrasse 50, 4056 Basel (Switzerland).
Abstract:
The lectin FimH is terminally expressed on type 1 pili of uropathogenic Escherichia coli (UPEC), which is the main cause of urinary tract infections (UTIs). FimH enables bacterial adhesion to urothelial cells, the initial step of infection. Various mannose derivatives have been shown to antagonize FimH and are therefore considered to be promising therapeutic agents for the treatment of UTIs. As part of the preclinical development process, when the kinetic properties of FimH antagonists were examined by surface plasmon resonance, extremely low dissociation rates (k(off)) were found, which is uncommon for carbohydrate-lectin interactions. As a consequence, the corresponding half-lives (t₁/₂) of the FimH antagonist complexes are above 3.6 h. For a therapeutic application, extended t₁/₂ values are a prerequisite for success, since the target occupancy time directly influences the in vivo drug efficacy. The long t₁/₂ value of the tested FimH antagonists further confirms their drug-like properties and their high therapeutic potential.
More Related Videos
13:57Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
Published on: February 18, 2014
14:09Fluorescence Biomembrane Force Probe: Concurrent Quantitation of Receptor-ligand Kinetics and Binding-induced Intracellular Signaling on a Single Cell
Published on: August 4, 2015
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Selectins
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Enzyme Inhibition
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...